Fintech PR
Holiston Media Reveals the Winners of This Year’s Global Forex Awards 2021 – Retail
Some of the biggest names in forex join the list of winners in this year’s Global Forex Awards 2021 – Retail, one of the world’s leading awards for the forex and financial industries.
Now in their fourth year, The Global Forex Awards 2021 – Retail celebrate those forex and related businesses from around the world who are pushing the boundaries of innovation in retail forex trading solutions.
The awards highlight those businesses at the forefront of cutting-edge technology, low-cost trading, comprehensive market research tools, advanced educational programs and world-class customer service for direct to consumer/trader businesses, with 58 categories comprising of global award winners, as well as regional award winners which cover specific territories, including Africa, Asia, Europe and the Middle East.
“We have set out to create the most transparent and trustworthy awards for the global forex retail industry and this year’s have been the most successful to date with more nominations and votes than ever before,” explains Mike Boydell, Director of Holiston Media. “Each of this year’s winners have been voted for by their peers and customers and chosen for their world class service; winning an award is a fantastic mark of trust and success in this highly competitive industry.”
The public voting process for the awards took place throughout July 2021 with over 31,000 votes cast from over 4,000 unique voters. This year’s category winners are as follows:
Award Category – Global
Best Affiliate Programme – Global |
RoboForex |
Best Forex Copy Trading Platform – Global |
AMarkets |
Best Forex Customer Service – Global |
Tickmill |
Best Forex EA – Global |
Forex Forest |
Best Forex ECN Broker – Global |
KEY TO MARKETS |
Best Forex Educational Resources – Global |
Eightcap |
Best Forex Educators – Global |
Axiory Intelligence |
Best Forex Fintech Broker – Global |
ATFX |
Best Forex Introducing Broker Programme – Global |
INFINOX |
Best Forex Media Provider – Global |
GAME CHANGERS MAGAZINE |
Best Forex Mobile Trading Platform /App – Global |
FXCM |
Best MT4 Broker – Global |
ATFX |
Best MT5 Broker – Global |
RoboMarkets |
Best Forex Partners Programme – Global |
HotForex |
Best Forex Technology Provider – Global |
Exclusive Markets |
Best Forex Trade Execution – Global |
KEY TO MARKETS |
Best Forex Trading Experience – Global |
KVB Prime |
Best Forex Trading Innovation – Global |
ADSS |
Best Forex Trading Platform – Global |
Saxo Bank |
Best Forex Trading Support – Global |
Accuindex |
Best Value Broker – Global |
FP Markets |
Most Transparent Forex Broker – Global |
Hantec Markets |
Most Trusted Forex Broker – Global |
XM |
Global Forex Newcomer of the Year |
AximTrade |
Global Forex Broker of the Year |
XM |
Award Category – Africa
Best Forex Copy Trading Platform – Africa |
INFINOX |
Best Forex Introducing Broker Programme – Africa |
AximTrade |
Best Forex Trading Experience – Africa |
FXTM |
Best Forex Trading Platform – Africa |
ThinkMarkets |
Best Forex Trading Support – Africa |
FXTM |
Best Value Broker – Africa |
Pepperstone Markets Kenya Limited |
Most Transparent Forex Broker – Africa |
Hantec Markets |
Most Trusted Forex Broker – Africa |
Hantec Markets |
Award Category – Asia
Best Forex Copy Trading Platform – Asia |
Samtrade FX |
Best Forex Fintech Broker – Asia |
Mitrade |
Best Forex Introducing Broker Programme – Asia |
AximTrade |
Best Forex Trading Experience – Asia |
Tickmill |
Best Forex Trading Platform – Asia |
AximTrade |
Best Forex Trading Support – Asia |
IG |
Best Value Broker – Asia |
AMarkets |
Most Transparent Forex Broker – Asia |
Axiory |
Most Trusted Forex Broker – Asia |
HotForex |
Award Category – Europe
Best Forex Affiliate Broker Programme – Europe |
Axi |
Best Forex Fintech Broker – Europe |
IEXS |
Best Forex Trading Experience – Europe |
FP Markets |
Best Forex Trading Platform – Europe |
FXCM |
Best Forex Trading Support – Europe |
Eightcap |
Best Value Broker – Europe |
RoboMarkets |
Most Transparent Forex Broker – Europe |
FXCM |
Most Trusted Broker – Europe |
RoboMarkets |
Award Category – Middle East
Best Forex Copy Trading Platform – Middle East |
INFINOX |
Best Forex Introducing Broker Programme – Middle East |
ATFX |
Best Forex Trading Experience – Middle East |
Tickmill |
Best Forex Trading Platform – Middle East |
ADSS |
Best Forex Trading Support – Middle East |
Accuindex |
Best Value Broker – Middle East |
Pepperstone Financial Services (DIFC) Limited |
Most Transparent Forex Broker – Middle East |
Axi |
Most Trusted Forex Broker – Middle East |
ADSS |
This year’s Global Forex Awards 2021 – Retail are sponsored by: Accuindex, AMarkets, ATFX, AximTrade, Axiory, Eightcap, Forex Forest, FP Markets, FXCM, Hot Forex, IEXS, INFINOX, Key to Markets, KVB Prime, Mitrade, RoboForex, RoboMarkets, Tickmill and XM.
“We’d like to congratulate all of this year’s winners who have proven that they are at the very top of their game in the global forex retail industry. The Global Forex Awards 2021 – Retail are a true benchmark for success that will not only impress potential new customers, but will also boost existing client comfort and loyalty.” concludes Mike.
Founded in 2018 to celebrate creativity, innovation, effectiveness and customer service in the retail and B2B financial industry, today Holiston Media hosts five international awards.
To find out more about the awards, the winners and the voting process go to https://www.globalforexawards.com.
For more information on Holiston Media and visit www.holiston.com.
Fintech PR
Invitation to presentation of EQT AB’s Q1 Announcement 2024
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
Fintech PR
Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
Fintech PR
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News7 days ago
Money20/20 Asia 2024: Days Two Roundup
-
Latest News4 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News7 days ago
Stripe Unveils Unbundled Payments Strategy in Fintech Pivot
-
Latest News3 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News7 days ago
Zafin Unveils Strategic Leadership Transition in Canadian SaaS Fintech
-
Latest News6 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News6 days ago
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%